| Fund Name | Location |
| Aheim Capital | Bayern, Germany, Munich |
| Amar Foundation | District of Columbia, United States, Washington |
| Analytics Ventures | California, San Diego, United States |
| CanQbate | - |
| CIKONI | - |
| Esco Ventures | Central, Central Region, Singapore |
| Ferring Pharmaceuticals | Saint-prex, Switzerland, Vaud |
| J Ventures | New York, New York, United States |
| Makower Family Trust | California, San Francisco, United States |
| Metropolitan Capital | Chicago, Illinois, United States |
| Muzhitong Technology | China, Hubei, Wuhan |
| NTT East | Japan, Tokyo |
| Sansar Capital | Central, Central Region, Singapore |
| Stage 2 Capital | New York, New York, United States |
| Taihecap (Formerly TH Capital) | Beijing, Beijing, China |
| Xuebao No.1 | Beijing, China, Haidian |
| Yongfengsheng Touzi | China, Guangdong, Shenzhen |
| Zhongjinchuanhua (Ningbo) Industry Equity Investment Fund | China, Ningbo, Zhejiang |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 